Advice for Treating Patients With Lung Cancer
Mark G. Kris, MD, discusses what is most important in treating patients with lung cancer today.
Mark G. Kris, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses what is most important in treating patients with lung cancer today.
First, Kris says that at every decision point, physicians should look at all therapeutic options for each individual illness and patient. By not looking at these individual variations, patients are not receiving the more effective therapy that could be better for that individual person.
Kris also notes that a multiple modality concept should be used at this point in time as well. More options are available than before, such as surgery, ablation, or stereotactic body radiation therapy (SBRT). Physicians should not simply be switching to different chemotherapy, EGFR agents, or tyrosine kinase inhibitors (TKIs).
Brahmer Considers First-Line Immunotherapy Options in Metastatic NSCLC
February 17th 2025During a Case-Based Roundtable® event, Julie R. Brahmer, MD, MSC, reviewed the CheckMate 9LA, KEYNOTE-407, and POSEIDON trials of immunotherapy in patients with metastatic non–small cell lung cancer.
Read More
